Learning about
Faculty disclosure

Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Carlo Alviggi: Declared no potential confict of interest.

Claus Yding Andersen: Declared no potential conflict of interest.

Aydin Arici: Declare receipt of grants from MSD Serono and Ortho-McNeil.

Mario Ascoli: Declared receipt of grants and contracts from NIH.

Remi Dumollard: Declared no potential confict of interest.

Robert Fischer: Declared receipt of honoraria or consultation fees from Serono Symposia International Foundation and to be a member of Serono Symposia International Foundation Scientific Committee.

Georg Griesinger: Declared receipt of grants and contracts from Merck Serono, Ferring, Schering-Plough, IBSA, Kade-Besins and honoraria or consultation fees from Merck Serono, Ferring, Schering-Plough, IBSA, Kade-Besins.

Samir Hamamah: Declared receipt of grants or contracts from Ferring and honoraria or consultation fees from Ferring. Prof. Hamamah also disclosed that his presentation includes the use of off-labelled or otherwise non-approved use of product.

Josè A. Horcajadas: Declared no potential conflict of interest.

Semra Kahraman: Declared no potential conflict of interest.

William G. Kearns: Declared receipt of grants and contracts from Merck Serono and honoraria or consultation fees from Merck Serono. Declared to have participation in speaker’s bureau sponsored by Merck Serono.

N.S. Macklon: Declared receipt of research grants from Merck Serono, Ferring, Schering-Plough and Anecova and honoraria or consultation fees from Merck Serono, Schering-Plough and Anecova.

Antonis Makrigiannakis: Declared no potential conflict of interest.

Emre Seli: Declared receipt of honoraria or consultation fees from Molecular Biometrics, Inc. Declared to be a member of Molecular Biometrics, Inc. advisory board, board of directors or other similar group. He also declared to be a stakeholder in Molecular Biometrics, Inc. company (including such things as stock ownership, or options to buy, own, or have applied for patents related to a company’s product, receive royalties for previous activities, employment, consultation services, etc.).

Marc-André Sirard: Declared receipt of honoraria or consultation fees from EMD Serono Canada Inc. for a scientific presentation.

Bulent Urman: Declared no potential conflict of interest.

Hakan Yarali: Declared no potential confict of interest.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of January 27, 2010

Tamara Garrido
Marie Louise Grøndahl
Timur Gurgan
Erol Tavmergen